Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;8(1):89-100.
doi: 10.2217/fca.11.76.

Targeting cardiovascular disease with novel SIRT1 pathways

Affiliations
Review

Targeting cardiovascular disease with novel SIRT1 pathways

Zhao Zhong Chong et al. Future Cardiol. 2012 Jan.

Abstract

Sirtuin (the mammalian homolog of silent information regulation 2 of yeast Saccharomyces cerevisiae) 1 (SIRT1), a NAD-dependent histone deacetylase, has emerged as a critical regulator in response to oxidative stress. Through antagonism of oxidative stress-induced cell injury and through the maintenance of metabolic homeostasis in the body, SIRT1 can block vascular system injury. SIRT1 targets multiple cellular proteins, such as peroxisome proliferator-activated receptor-γ and its coactivator-1α, forkhead transcriptional factors, AMP-activated protein kinase, NF-κB and protein tyrosine phosphatase to modulate intricate cellular pathways of multiple diseases. In the cardiovascular system, activation of SIRT1 can not only protect against oxidative stress at the cellular level, but can also offer increased survival at the systemic level to limit coronary heart disease and cerebrovascular disease. Future knowledge regarding SIRT1 and its novel pathways will open new directions for the treatment of cardiovascular disease as well as offer the potential to limit disability from several related disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cell signaling of SIRT1 leads to cardiovascular protection
SIRT1 targets forkhead family member (FoxOs) to result in manganese superoxide dismutase (MnSOD) and the growth arrest and DNA damage (GADD45) expression to resist oxidative stress. Other SIRT1 substrates include peroxisome proliferators-activated receptor-γ (PPAR-γ) and its coactivator-1α (PGC-1α), peroxisome proliferators-activated receptor-α (PPARα), AMP activated protein kinase (AMPK), p53, nuclear factor-κB (NF-κB), and endothelial nitric oxide synthase (eNOS). The outcomes of regulating these signaling pathways by SIRT1 include protection of cardiomyocyte and endothelial cells, balance of lipid metabolism, inhibition of inflammation and atherosclerotic formation, and inhibition of cardiac hypertrophy.

Similar articles

Cited by

References

    1. Kelly GS. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Altern Med Rev. 2010;15(4):313–328. - PubMed
    1. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem. 2002;277(47):45099–45107. - PubMed
    1. Tanno M, Kuno A, Yano T, et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem. 2010;285(11):8375–8382. * Demonstrates that nuclear translocation of SIRT1 increases its activity and induces MnSOD to protect cardiomyocytes during heart failure.

    1. Hou J, Chong ZZ, Shang YC, Maiese K. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res. 2010;7(2):95–112. * Demonstrates that nuclear translocation of SIRT1 protects endothelial cells against oxidative stress.

    1. Hou J, Wang S, Shang YC, Chong ZZ, Maiese K. Erythropoietin Employs Cell Longevity Pathways of SIRT1 to Foster Endothelial Vascular Integrity During Oxidant Stress. Curr Neurovasc Res. 2011;8(3):220–235. - PMC - PubMed

Publication types

MeSH terms